Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial

Morillo, Carlos A., Verma, Atul, Connolly, Stuart J., Kuck, Karl H., Nair, Girish M., Champagne, Jean, Sterns, Laurence D., Beresh, Heather, Healey, Jeffrey S., Natale, Andrea, RAAFT-2 Investigators·2014·JAMA
DOI 10.1001/jama.2014.467

Cited by (667)

Items 201–300 of 667

  1. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy
    Yi Fang, Wenbo Hou, Chao Yu Zhou, Yuxia Yin, Shoutao Lu, Cuihai Duan, Mingkun Cao, Maoquan Li, Egon Steen Toft, Haijun Zhang · 2019 · Journal of Cardiovascular Pharmacology
  2. Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
    Fumi Yamagami, Kazuko Tajiri, Dai Yumino, Masaki Ieda · 2019 · Toxins
  3. Administration of Antiarrhythmic Drugs to Maintain Sinus Rhythm After Catheter Ablation for Atrial Fibrillation: A Meta‐Analysis
    Xiuli Xu, Choumi Tchamba Alida, Bo Yu · 2015 · Cardiovascular Therapeutics
  4. Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study
    Jean Sylvain Hermida, Jian Chen, Christian G. Meyer, Saverio Iacopino, Giuseppe Arena, Nikola Pavlović, Vedran Velagić, Stewart Healey, Douglas L. Packer, Heinz-Friedrich Pitschner et al. · 2019 · American Heart Journal
  5. Bias and Loss to Follow‐Up in Cardiovascular Randomized Trials: A Systematic Review
    Lucas Chun Wah Fong, Thomas Joseph Ford, Bruno R. da Costa, Peter Jüni, Colin Berry · 2020 · Journal of the American Heart Association
  6. Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) Registry
    Vassilios Pericles Vassilikos, Efstathios D. Pagourelias, Cécile Laroche, Carina Blomström‐Lundqvist, Josef Kautzner, Aldo Pietro Maggioni, Luigi Tavazzi, Nikolaos Dagres, Josép Brugada, M Stuehlinger et al. · 2020 · EP Europace
  7. Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis
    Hassan A. Alhassan, Aleesha Kainat, Joseph Patrick Donohue, Scott J. Baumgartner, Harriet Akunor, Samir Saba, Sandeep K Jain, Prem Soman · 2023 · Journal of the American Heart Association
  8. Atrial Fibrillation and Heart Failure: Cause or Effect?
    Christina L. Luong, Marion E. Barnes, Teresa S.M. Tsang · 2014 · Current Heart Failure Reports
  9. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding
    Daniel A.N. Mascarenhas, Mohammad Umar U. Farooq, Paul Ziegler, Bharat K. Kantharia · 2015 · EP Europace
  10. Individualized Ablation Strategy Guided By Live Simultaneous Global Mapping to Treat Persistent Atrial Fibrillation
    Rui Shi, Mark W. Norman, Zhong Chen, Tom Wong · 2018 · Future Cardiology
  11. Incidence and risk factors of post-operative cognitive decline after ablation for atrial fibrillation
    Jing Zhang, Shijun Xia, Xin Du, Chao Jiang, Yiwei Lai, Yufeng Wang, Zhaoxu Jia, Liu He, Ribo Tang, Jianzeng Dong et al. · 2021 · BMC Cardiovascular Disorders
  12. Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation
    Luiz Pereira de Magalhães, Márcio Jansen de Oliveira Figueiredo, Fátima Dumas Cintra, Eduardo Saad, Ricardo Ryoshim Kuniyoshi, Adalberto Menezes Lorga Filho, André d’Ávila, Ângelo Amato Vincenzo de Paola, Carlos Kalil, Dalmo Antônio Ribeiro Moreira et al. · 2016 · Arquivos Brasileiros de Cardiologia
  13. Factors Associated With Cardiac Electrophysiologist Assessment and Catheter Ablation Procedures in Patients With Atrial Fibrillation
    Sheldon M. Singh, Lauren E. Webster, Dennis T. Ko, Jack V. Tu, Harindra Channa Wijeysundera · 2016 · JACC. Clinical electrophysiology
  14. Ablação por Cateter é Superior a Drogas Antiarrítmicas como Tratamento de primeira linha para Fibrilação Atrial: uma Revisão Sistemática e Metanálise
    Rhanderson N. Cardoso, Gustavo Busch Justino, Fabrissio P. Graffunder, Leticia Benevides, Leonardo Knijnik, Luana M.F. Sanchez, André d’Ávila · 2022 · Arquivos Brasileiros de Cardiologia
  15. Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
    Mohammed Al‐Sadawi, Saadat Aleem, Faisal Aslam, Robin Jacobs, Gregg Stevens, Ibrahim O. Almasry, Abhijeet Singh, Roger Fan, Eric J. Rashba · 2022 · Heart Rhythm O2
  16. Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control
    Shaojie Chen, Yuehui Yin, Zhiyu Ling, Christian G. Meyer, Helmut Pürerfellner, Martin Martinek, Márcio Galindo Kiuchi, Piotr Futyma, Lin Zhu, Alexandra Schratter et al. · 2022 · Journal of Clinical Medicine
  17. Ablation as First-line Therapy for Atrial Fibrillation
    Jason G. Andrade · 2023 · European Cardiology Review
  18. Safety and acute efficacy of catheter ablation for atrial fibrillation with pulsed field ablation vs thermal energy ablation: A meta-analysis of single proportions
    Omar Mahmoud Aldaas, Chaitanya Malladi, Amer M Aldaas, Frederick T. Han, Kurt S. Hoffmayer, David E. Krummen, Gordon Ho, Farshad Raissi, Ulrika Maria Birgersdotter-Green, Gregory K. Feld et al. · 2023 · Heart Rhythm O2
  19. Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation
    Nicolás Vecchio · 2019 · Journal of Atrial Fibrillation
  20. Conventional versus 3‐D Echocardiography to Predict Arrhythmia Recurrence After Atrial Fibrillation Ablation
    Matthias Bossard, Sven Knecht, Stefanie Aeschbacher, Ronny R. Buechel, Thomas Hochgruber, ANDREAS J. ZIMMERMANN, Arnheid Kessel-Schaefer, Frank‐Peter Stephan, Gian Voellmin, Maurice Pradella et al. · 2017 · Journal of Cardiovascular Electrophysiology
  21. Long‐term risk of stroke and bleeding post–atrial fibrillation ablation
    Jacqueline E. Joza, Michelle Samuel, Cynthia Anne Jackevicius, Hassan Behlouli, Jing Jia, Maria Koh, Meytal Avgil Tsadok, ANTHONY S.L. TANG, Atul Verma, Louise Pilote et al. · 2018 · Journal of Cardiovascular Electrophysiology
  22. Reflections on the usefulness of today’s atrial fibrillation ablation procedure endpoints and patient-reported outcomes
    Carina Blomström‐Lundqvist, Victoria Svedung Wettervik · 2021 · EP Europace
  23. Clinical Role of Dominant Frequency Measurements in Atrial Fibrillation Ablation – A Systematic Review
    Lucaz Gadenz, Javad Hashemi, Mohammad Hassan Shariat, Lorne J. Gula, Damian Redfearn · 2017 · Journal of Atrial Fibrillation
  24. Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death
    Daniel Modin, Brian Lee Claggett, Gunnar Gislason, Morten Lock Hansen, Rene Husted Worck, Arne Cyron Johannessen, Jim Hansen, Jesper Hastrup Svendsen, Jannik Langtved Pallisgaard, Morten Schou et al. · 2019 · EP Europace
  25. What clinical trials of ablation for atrial fibrillation tell us – and what they do not
    Ram Amuthan, Anne B. Curtis · 2021 · Heart Rhythm O2
  26. US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
    Jonathan G. Tardos, Christopher J. Ronk, Miraj Y. Patel, Andrew Koren, Michael Kim · 2021 · Journal of the American Heart Association
  27. RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation
    Riyaz A. Kaba, Douglas Ewan Cannie, Omar Ahmed · 2014 · Global Cardiology Science and Practice
  28. Differences in Quality of Life Between Atrial Fibrillation Patients with Low Stroke Risk Treated With and Without Catheter Ablation
    Ying Bai, Rong Bai, Jiahui Wu, Ting Zhang, Nian Liu, Xu‐Bo Shi, Xinyao Liu, Xiaohui Liu, Xin Du, Jianzeng Dong et al. · 2015 · Journal of the American Heart Association
  29. Pulmonary Hypertension due to Radiofrequency Catheter Ablation (RFCA) for Atrial Fibrillation: The Lungs, the Atrium or the Ventricle?
    Isha Verma, Hemantkumar Tripathi, Rutuja Sikachi, Abhinav Agrawal · 2016 · Heart Lung and Circulation
  30. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis
    Subhash Chander, Roopa Kumari, Sindhu Luhana, Sheena Shiwlani, Om Parkash, Fnu Sorath, Hong Yu Wang, Sam Tan, Zubair Rahaman, Yaqub Nadeem Mohammed et al. · 2024 · BMC Cardiovascular Disorders
  31. Catheter Ablation for “Lone” Atrial Fibrillation: Efficacy and Predictors of Recurrence
    Alessandra Buiatti, Bernhard M. Kaess, Tilko Reents, Verena Semmler, M. TELISHVESKA, Felix J. Bourier, M. Kornmayer, Marc Kottmaier, Gabriele Hessling, Isabel Deisenhofer · 2016 · Journal of Cardiovascular Electrophysiology
  32. Atrial Fibrillation and Deterioration in Cognitive Function
    Viswanatha Chinta, Sameh Askandar, Amit S. Nanda, Arindam Sharma, Peter Abader, Rajesh Kabra, Rami N. Khouzam · 2018 · Current Problems in Cardiology
  33. General anesthesia or conscious sedation in paroxysmal atrial fibrillation catheter ablation
    Ondřej Moravec, Tomáš Skála, Olga Klementová, Jitka Skalova, Martin Hutyra, Jan Přeček, Marián Fedorco, Vlastimil Černíček, Zbyněk Tüdös, Jana Zapletalová et al. · 2020 · Biomedical Papers
  34. Ablation of Complex Fractionated Atrial Electrograms for Atrial Fibrillation Rhythm Control: A Systematic Review and Meta-analysis
    Opeyemi O. Fadahunsi, Taiwo Talabi, Abiola Olowoyeye, Anthony Iluyomade, Oluwaseun Shogbesan, Anthony Andrew Donato · 2015 · Canadian Journal of Cardiology
  35. Cost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies
    Tina D. Hunter, Swetha Rao Palli, John A. Rizzo · 2016 · Journal of Medical Economics
  36. Healthcare Utilization and Quality of Life Improvement after Ablation for Paroxysmal AF in Younger and Older Patients
    ANGELO B. BIVIANO, Tina D. Hunter, Gopi Dandamudi, Robert Fishel, Brett Gidney, Bengt Herweg, Saumil R. Oza, Anshul M. Patel, HUIJIAN WANG, Scott J. Pollak · 2017 · Pacing and Clinical Electrophysiology
  37. Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation
    Keiko Shimamoto, Fumiharu Miura, Yuji Shimatani, Kenji Nishioka, Ichiro Inoue · 2018 · PLoS ONE
  38. Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta‐analysis
    Pradyumna Agasthi, Justin Z. Lee, Mustapha Amin, Farah Al‐Saffar, Vasudha Goel, Andrew S. Tseng, Diana Almader‐Douglas, Ammar M. Killu, Abhishek J. Deshmukh, Freddy Del‐Carpio Munoz et al. · 2019 · Journal of Arrhythmia
  39. Study on the relationship between telomere length changes and recurrence of atrial fibrillation after radiofrequency catheter ablation
    Changyang Su, Zheng Liu, Yuanfeng Gao, Ye Liu, Roumu Hu, Jia Liu, Xiyan Yang, Shichao Li, Yuan Zhang, Kun Zuo et al. · 2019 · Journal of Cardiovascular Electrophysiology
  40. Contributors Toward Pulmonary Vein Restenosis Following Successful Intervention
    Robert Jay Widmer, Erin Amanda Fender, David O. Hodge, Kristi H. Monahan, Lori Ann Peterson, David R. Holmes, Douglas L. Packer · 2017 · JACC. Clinical electrophysiology
  41. Bayesian network meta‐analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation
    Mahmoud Elsayed, Omar Abdelfattah, Ahmed Sayed, Rohan Madhu Prasad, Amr F. Barakat, Islam Y. Elgendy, Jason G. Andrade, Thomas Jared Bunch, Amit J. Thosani, Walid I. Saliba et al. · 2021 · Journal of Cardiovascular Electrophysiology
  42. Paroxysmal Atrial Fibrillation in Horses: Pathophysiology, Diagnostics and Clinical Aspects
    Sofie Troest Kjeldsen, Sarah Dalgas Nissen, Rikke Buhl, Charlotte C. S. Hopster-Iversen · 2022 · Animals
  43. Management of Atrial Fibrillation in Elderly Adults
    Yaanik B. Desai, Mikhael F. El‐Chami, Angel R. León, Faisal M. Merchant · 2016 · Journal of the American Geriatrics Society
  44. Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms
    Nikola Pavlović, Gian‐Battista Chierchia, Vedran Velagić, Jean Sylvain Hermida, Stewart Healey, Giuseppe Arena, Nicolas Badenco, Christian G. Meyer, Jian Chen, Saverio Iacopino et al. · 2021 · American Heart Journal
  45. Type and rate of atrial fibrillation termination due to rotational activity ablation combined with pulmonary vein isolation
    Zsuzsanna Kis, Dominic A.M.J. Theuns, Rohit E. Bhagwandien, Sip A. Wijchers, Sing‐Chien Yap, Tamás Szili‐Törok · 2017 · Journal of Cardiovascular Electrophysiology
  46. The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST
    Elena Arbelo, Nikolaos Dagres · 2022 · EP Europace
  47. Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence
    Girish M. Nair, David H. Birnie, Pablo B. Nery, Calum J. Redpath, JEAN‐FRANÇOIS SARRAZIN, Jean-François Roux, Ratika Parkash, Martin Bernier, Laurence D. Sterns, John L. Sapp et al. · 2023 · JAMA Cardiology
  48. Second generation cryoballoon ablation for atrial fibrillation in young adults: midterm outcome in patients under 40 years of age
    Darragh Moran, Valentina De Regibus, Carlo de Asmundis, Ken Takarada, Giacomo Mugnai, Erwin Ströker, Arash Aryana, Saverio Iacopino, Diego Ruggiero, Hugo Enrique Coutiño-Moreno et al. · 2016 · EP Europace
  49. Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold‐tip catheter: REDUCE‐TE Pilot study
    Boris Schmidt, Gábor Széplaki, Béla Péter Merkely, Josef Kautzner, Vincent van Driel, Felix J. Bourier, Malte Kuniss, Alan Bulava, Georg Nölker, Muchtiar Khan et al. · 2019 · Journal of Cardiovascular Electrophysiology
  50. Pharmacological Tests in Atrial Fibrillation Ablation
    Jean‐Baptiste Gourraud, Jason G. Andrade, Laurent Macle, Blandine A. Mondesert · 2016 · Arrhythmia & Electrophysiology Review
  51. Clinical, electrophysiological and imaging predictors of atrial fibrillation ablation outcome
    Louisa O’Neill, James Harrison, Mark D O'Neill, Steven Edwin Williams · 2017 · Expert Review of Cardiovascular Therapy
  52. Quality of Life and Safety Outcomes after First-Line Treatment of Symptomatic AF with Cryoablation or Drug Therapy: A Meta-Analysis of Randomized Controlled Trials
    Qingchun Song, Haoyu Tan, Benli Yang, Hongduan Liu, Chengming Fan · 2024 · Reviews in Cardiovascular Medicine
  53. Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Waqas Ullah, Drew M. Johnson, Abhinav Nair, Sean J. Dikdan, Eitan Frankel, Wajahat Humayun, Behzad B. Pavri, Daniel R. Frisch · 2023 · The American Journal of Cardiology
  54. Contemporary Challenges of Catheter Ablation for Atrial Fibrillation
    Rukshen Weerasooriya, Ashok J. Shah, Mélèze Hocini, Pierre Jaı̈s, Michel Haı̈ssaguerre · 2014 · Clinical Therapeutics
  55. Baseline and Postprocedural Health Status Outcomes in Contemporary Patients With Atrial Fibrillation Who Underwent Catheter Ablation: A Report from the Japanese Outpatient Registry
    Nobuhiro Ikemura, John A. Spertus, Takehiro Kimura, Yoshinori Katsumata, Taishi Fujisawa, Ikuko Ueda, Keiichi Fukuda, Seiji Takatsuki, Shun Kohsaka · 2021 · Journal of the American Heart Association
  56. Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis
    Radhika Deshpande, Yasser Al‐Khadra, PRASHANTH M SINGANALLUR, Albert Botchway, Mohamed Rafa Labedi · 2022 · Journal of Interventional Cardiac Electrophysiology
  57. Atrial Fibrillation Ablation: Indications, Emerging Techniques, and Follow-Up
    Edward P. Gerstenfeld, Srikant Duggirala · 2015 · Progress in Cardiovascular Diseases
  58. Mechanisms Underlying AF: Triggers, Rotors, Other?
    David E. Krummen, Shrinivas Hebsur, Jon Salcedo, Sanjiv M. Narayan, Gautam Lalani, Amir A Schricker · 2015 · Current Treatment Options in Cardiovascular Medicine
  59. Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.
    Ya-Ru Zheng, Zhiyun Chen, Lifang Ye, Lihong Wang · 2015 · Europe PMC (PubMed Central)
  60. Atrial Fibrillation: Beyond Rate Control
    Subir Bhatia, Alan M. Sugrue, Samuel J. Asirvatham · 2018 · Mayo Clinic Proceedings
  61. Robotic Ablation of Atrial Fibrillation
    Alexander Wutzler, Thomas Wölber, Wilhelm Haverkamp, Leif‐Hendrik Boldt · 2015 · Journal of Visualized Experiments
  62. Atrial fibrillation catheter ablation: an updated review of current guidelines and expert consensus documents
    Mohammadali Habibi, Hugh G Calkins · 2019 · Herzschrittmachertherapie + Elektrophysiologie
  63. Initial experience with zero-fluoroscopy pulmonary vein isolation in patients with atrial fibrillation: single-center observational trial
    Dalma Torma, Kristof-Ferenc Janosi, Dorottya Debreceni, Botond Bocz, Mark Keseru, Tamás Símor, Péter Kupó · 2024 · Scientific Reports
  64. Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future
    Jeffrey J. Goldberger, Raul David Mitrani, Ghaith Zaatari, Sanjiv M. Narayan · 2024 · Circulation Arrhythmia and Electrophysiology
  65. Vein of Marshall ethanol infusion for recurrent atrial fibrillation in patients with durably isolated pulmonary veins
    Gregory J. Cunn, Apoor Patel, Kristie M. Coleman, Eric Dulmovits, Nicholas T. Skipitaris, Laurence Mark Epstein, Stavros Mountantonakis, STUART J. BELDNER · 2024 · Journal of Interventional Cardiac Electrophysiology
  66. Catheter ablation for atrial fibrillation and impact on clinical outcomes
    Rui Andre Providencia, Hussam Ali, António Creta, Sérgio Barra, Prapa Kanagaratnam, RICHARD JOHN SCHILLING, Michał M. Farkowski, Riccardo Cappato · 2024 · European Heart Journal Open
  67. Pulmonary vein isolation with or without empiric superior vena cava isolation in patients undergoing ablation for paroxysmal atrial fibrillation: the randomized ESVCI-AF trial
    Wenzhi Shen, Yuzhen Zhang, Weichun Qian, Chengzong Li, Cheng Wang, Wei Li, Jian Li, Juan Chen, Youquan Wei, Yu Liu et al. · 2025 · EP Europace
  68. Ablation of atrial fibrillation
    Matthew James Wright, Sanjiv M. Narayan · 2014 · Trends in Cardiovascular Medicine
  69. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation
    Mihoko Kawabata, Masahiko Goya, Takamitsu Takagi, Shu Yamashita, Shinsuke Iwai, Masahito Suzuki, Tomomasa Takamiya, Tomofumi Nakamura, Tatsuya Hayashi, Atsuhiko Yagishita et al. · 2016 · Journal of Cardiology
  70. Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
    Yuling Jing, Ruixue Yang, Wen Chen, Qiang Ye · 2022 · Frontiers in Pharmacology
  71. Safety and effectiveness of very-high-power, short-duration ablation in patients with atrial fibrillation: Preliminary results
    Karolina Mitrzak, Michał Peller, Bartosz Krzowski, Cezary Maciejewski, Paweł Balsam, Michał Marchel, Marcin Grabowski, Piotr Lodziński · 2023 · Cardiology Journal
  72. Early Detection of Symptomatic Paroxysmal Cardiac Arrhythmias by Trans‐Telephonic ECG Monitoring: Impact on Diagnosis and Treatment of Atrial Fibrillation
    JOHANNA ANCZYKOWSKI, Stephan Willems, Boris Alexander Hoffmann, Thomas Meinertz, Stefan Blankenberg, Monica Patten · 2016 · Journal of Cardiovascular Electrophysiology
  73. Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study
    Robert N. D’Angelo, Rahul Khanna, Robert W. Yeh, Laura J. Goldstein, Iftekhar D. Kalsekar, Stephen R. Marcello, Patricia Tung, PETER J. ZIMETBAUM · 2020 · BMC Cardiovascular Disorders
  74. Meta-Analysis of Catheter Ablation versus Medical Therapy in Patients with Atrial Fibrillation Without Heart Failure
    Dhanunjaya Lakkireddy · 2020 · Journal of Atrial Fibrillation
  75. Presence of a left common pulmonary vein and pulmonary vein anatomical characteristics as predictors of outcome following cryoballoon ablation for paroxysmal atrial fibrillation
    Abhishek Bose, Parag Anilkumar Chevli, Gregory Berberian, Jerzy Januszkiewicz, Ghasan Ahmad, Zeba Hashmath, Ajay Kumar Mishra, Douglas W. Laidlaw · 2020 · Journal of Interventional Cardiac Electrophysiology
  76. First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation
    Massimo Moltrasio, Saverio Iacopino, Giuseppe Arena, Paolo Pieragnoli, Giulio Molon, Massimiliano Manfrin, Roberto Verlato, Luca Ottaviano, Giovanni Rovaris, Domenico Catanzariti et al. · 2021 · Journal of Cardiovascular Medicine
  77. Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes
    Medhat Farwati, Oussama M. Wazni, Khaldoun G. Tarakji, Mohamed Diab, Anna L. Scandinaro, Mustapha Amin, Mohammad A. Zmaili, Najdat Bazarbashi, Ozan Dikilitas, Hiroshi Nakagawa et al. · 2021 · Circulation Arrhythmia and Electrophysiology
  78. Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
    Sean D. Pokorney, James P. Daubert · 2018 · European Heart Journal
  79. Effect of catheter ablation on the hemodynamics of the left atrium
    Brennan J. Vogl, Ahmed El Shaer, Martin van Zyl, Ammar M. Killu, Mohamad Adnan Alkhouli, Hoda Hatoum · 2022 · Journal of Interventional Cardiac Electrophysiology
  80. Best Practice Guide for Cryoballoon Ablation in Atrial Fibrillation: The Compilation Experience of More than 1000 Procedures
    Dimitris Tsiachris, Christos Konstantinos Antoniou, Ioannis Doundoulakis, Panagiota Manolakou, Demetrios Sougiannis, Athanasios Kordalis, Konstantinos A. Gatzoulis, Gian‐Battista Chierchia, Carlo de Asmundis, Christodoulos Stefanadis et al. · 2023 · Journal of Cardiovascular Development and Disease
  81. Atrial fibrillation ablation timing: where is the sweet spot?
    Jonathan M. Kalman, Peter M. Kistler, Gerhard Hindricks, Prashanthan Sanders · 2025 · European Heart Journal
  82. WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
    Hugh G Calkins, Gerhard Hindricks, Riccardo Cappato, Young‐Hoon Kim, Eduardo Saad, Luis Aguinaga, Joseph G. Akar, Vinay Badhwar, Josép Brugada, A. John Camm et al. · 2017 · Journal of Arrhythmia
  83. Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation
    Yusuke Sakamoto, Hiroyuki Osanai, Shotaro Hiramatsu, Hikari Matsumoto, Kensuke Tagahara, Hirotaka Hosono, Shun Miyamoto, Hiroto Uno, Hideki Kurokawa, Shun Kondo et al. · 2020 · BMC Cardiovascular Disorders
  84. Catheter ablation improves outcomes and quality of life in Japanese patients with early-stage atrial fibrillation: A retrospective cohort study
    Yuta Seki, Taishi Fujisawa, Nobuhiro Ikemura, Susumu Ibe, Ippei Tsuzuki, Kenji Hashimoto, Terumasa Yamashita, Hiroshi Miyama, Nozomi Niimi, Masahiro Suzuki et al. · 2022 · Heart Rhythm
  85. Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method
    Sabrina Trippoli, Lorenzo Di Spazio, Marco Chiumente, Andrea Messori · 2022 · Cureus
  86. Similarities between the renal artery and pulmonary vein denervation trials: Do we have to use sham procedures for atrial fibrillation catheter ablation trials?
    Özcan Özeke, Serkan Çay, Fırat Özcan, Kazım Başer, Serkan Topaloğlu, Dursun Aras · 2016 · International Journal of Cardiology
  87. Meta-analysis of medical management versus catheter ablation for atrial fibrillation
    Yinjun Mao, Hang Wang, Jianxing Chen, Pinfang Huang · 2020 · Reviews in Cardiovascular Medicine
  88. Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review
    Abdullah Alrumayh, Muath Alobaida · 2021 · Annals of Medicine
  89. The Role of Atrial Fibrosis Detected by Delayed - Enhancement MRI in Atrial Fibrillation Ablation
    Zsuzsanna Kis, Astrid Amanda Hendriks, Taulant Muka, Wichor Matthijs Bramer, István Kovács, Tamás Szili‐Törok · 2018 · Current Medical Imaging Formerly Current Medical Imaging Reviews
  90. Cryoballoon ablation for atrial fibrillation in octogenarians: a propensity score-based analysis with a younger cohort
    Federico Cecchini, Giacomo Mugnai, Shuichiro Kazawa, Bruna Bolzan, Saverio Iacopino, Riccardo Maj, Filippo Placentino, Flavio Luciano Ribichini, Juan Antonio Sieira, Dimitrios Sofianos et al. · 2023 · Journal of Cardiovascular Medicine
  91. Pulsed field ablation for pulmonary vein isolation: Preclinical safety and effectiveness of a novel hexaspline ablation catheter
    Fengyuan Yu, Xiaonan Dong, Lei Ding, Vivek Yerrapu Reddy, Min Tang · 2023 · Journal of Cardiovascular Electrophysiology
  92. High-frequency low-tidal volume ventilation improves procedural and long-term clinical outcomes in persistent atrial fibrillation ablation: Prospective multicenter registry
    José Osorio, Daniela Hincapie, Allyson L. Varley, Joshua R. Silverstein, Carlos D. Matos, Amit J. Thosani, Christopher Thorne, Benjamin Anthony D'Souza, Isabella Alviz, Mohamed Gabr et al. · 2024 · Heart Rhythm
  93. Association between comorbidity burden and outcomes of catheter ablation vs. medical therapy for atrial fibrillation: insights from the CABANA trial
    Yang Chen, Eva Soler‐Espejo, Manlin Zhao, Wenhui Li, Hongyu Liu, Ying Xuan Gue, Garry McDowell, Douglas L. Packer, Gregory Y.H. Lip · 2025 · EP Europace
  94. Factors associated with the efficacy of atrial fibrillation radiofrequency catheter ablation: opinion of the specialists who use the “ablation index” module
    Evgeny N. Mikhaylov, Nigar Z. Gasimova, S. A. Ayvazyan, Е. А. Artyukhina, Громыко Григорий Алексеевич, Э. А. Иваницкий, Г. В. Колунин, А. Н. Морозов, Sh. G. Nardaya, M. S. Rybachenko et al. · 2020 · Journal of Arrhythmology
  95. Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry
    Giulio Zucchelli, K. R. Julian Chun, Surinder Kaur Khelae, Csaba Földesi, Fred J. Kueffer, Kelly Anna van Bragt, Fernando Scazzuso, Young Keun On, Fawzia Al‐Kandari, Ken Okumura et al. · 2022 · Journal of Interventional Cardiac Electrophysiology
  96. Durability of CLOSE-Guided Pulmonary Vein Isolation in Persistent Atrial Fibrillation
    Oskar Galuszka, Samuel H. Baldinger, Helge Servatius, Jens Seiler, Antonio Madaffari, Nikola Kozhuharov, Gregor Thalmann, Thomas Kueffer, Aline Muehl, Jens Maurhofer et al. · 2024 · JACC. Clinical electrophysiology
  97. Impact of Stable Coronary Artery Disease on the Efficacy of Cryoballoon Ablation for the Atrial Fibrillation
    Lu Liu, Dongdong Zhao, Jun Zhang, Haotian Yang, Fuad A. Abdu, Rong Guo, Shuang Li, Kai Tang, Hailing Li, Wenliang Che et al. · 2019 · The American Journal of the Medical Sciences
  98. Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation
    Yoshinori Katsumata, Shun Kohsaka, Nobuhiro Ikemura, Ikuko Ueda, Kenji Hashimoto, Terumasa Yamashita, Hiroshi Miyama, Taishi Fujisawa, Takehiro Kimura, Kojiro Tanimoto et al. · 2020 · JACC. Clinical electrophysiology
  99. Management of arrhythmias in pulmonary hypertension
    Sathineni Ashwin Reddy, Sarah L. Nethercott, Bharat Vashdev Khialani, Andrew A. Grace, Claire Martin · 2021 · Journal of Interventional Cardiac Electrophysiology
  100. Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis
    Andrea Messori, Laura Bartoli, Elisa Ferracane, Sabrina Trippoli · 2021 · Reviews in Cardiovascular Medicine